Evantas Biotec Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
- Paid Up Capital ₹ 0.50 M
- Company Age 12 Year, 8 Months
- Last Filing with ROC 31 Mar 2022
- Open Charges ₹ 0.50 M
- Revenue Growth 7.63%
- Profit Growth 194.19%
- Ebitda 142.88%
- Net Worth 16.11%
- Total Assets -12.89%
About Evantas Biotec
Evantas Biotec Private Limited (EBPL) is a Private Limited Indian Non-Government Company incorporated in India on 14 June 2012 and has a history of 12 years and eight months. Its registered office is in Bangaluru, Karnataka, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2022. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.50 M.
The company currently has active open charges totaling ₹0.50 M.
Jagadeesh Nanjundaiah and Janardhan Bandi serve as directors at the Company.
Company Details
-
Location
Bangaluru, Karnataka, India
-
Telephone
+91-XXXXXXXXXX
- Email Address
-
Website
-
-
Social Media
-
Corporate Identity Details
-
CIN/LLPIN
U24132KA2012PTC064392
-
Company No.
064392
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
14 Jun 2012
-
Date of AGM
30 Sep 2022
-
Date of Balance Sheet
31 Mar 2022
-
Listing Status
Unlisted
-
ROC Code
Roc Bangalore
Industry
What products or services does Evantas Biotec Private Limited offer?
Evantas Biotec Private Limited offers a wide range of products and services, including Ayurvedic & Herbal Extracts, Plant Extracts.
Who are the key members and board of directors at Evantas Biotec?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Jagadeesh Nanjundaiah
|
Managing Director | 14-Jun-2012 | Current |
Board Members (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
|
Janardhan Bandi
|
Director | 14-Jun-2012 | Current |
Financial Performance of Evantas Biotec.
Evantas Biotec Private Limited, for the financial year ended 2020, experienced modest growth in revenue, with a 7.63% increase. The company also saw a substantial improvement in profitability, with a 194.19% increase in profit. The company's net worth Soared by an impressive increase of 16.11%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Evantas Biotec?
In 2017, Evantas Biotec had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
₹0.50 M
₹0
Charges Breakdown by Lending Institutions
- Others : 0.05 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 05 Mar 2020 | Others | ₹0.50 M | Open |
How Many Employees Work at Evantas Biotec?
Unlock and access historical data on people associated with Evantas Biotec, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Evantas Biotec, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Evantas Biotec's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
